Oscar Health

Oscar Health, Inc. operates as a health insurance company which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Oscar Health reports robust growth and profitability outlook for 2023

Oscar Health's 2022 performance showcased strong growth in membership, improved financial ratios, and a focus on efficiency and profitability in the insurance business.
The company's strengths lie in exceeding targets for capital, stable premiums, and leveraging investment income for competitive advantage.
Challenges include financial transparency and managing risk pool dynamics, while opportunities exist in market expansion, PBM contract benefits, and margin expansion strategies.
Overall, Oscar Health's strategic focus on growth, efficiency, and profitability positions it well for future success in the insurance market.

Oscar Health achieves Q1 profitability, focuses on tech innovation

Oscar Health's Q1 2023 earnings call highlighted strong financial performance, operational efficiency, and a strategic focus on profitability priorities.
While facing challenges such as reshaping strategies and market-specific dynamics, the company is well-positioned to leverage opportunities for growth and innovation.
With a mission-driven approach, a growing member base, and a commitment to enhancing technology, Oscar Health aims to sustain profitability and market competitiveness.

Oscar Health reports strong Q2 earnings, eyes growth opportunities

Oscar Health's Q2 performance reflects positive trends in profitability, membership growth, and strategic planning for future expansion.
While facing challenges in pricing strategies and achieving profitability targets, the company is well-positioned to capitalize on growth opportunities.
With a focus on innovation, customer satisfaction, and market expansion, Oscar Health aims to strengthen its competitive position in the healthcare industry.

Oscar Health excels in Q3, eyes profitability in 2024

Oscar Health's Q3 2023 earnings call highlighted strong performance metrics, a focus on profitability in 2024, and strategic initiatives to drive growth and enhance member satisfaction. While facing challenges in narrowing EBITDA losses, the company remains optimistic about its trajectory and expressed confidence in its strategic direction and employee dedication.

Oscar Health achieves insurance profitability, eyes growth amid market changes

Oscar Health's Q4 2023 Earnings Call highlighted achievements in insurance company profitability and significant improvements in total company adjusted EBITDA.
The company is well-positioned for profitability in 2024, focusing on serving over 1.3 million members with new products and technology enhancements.
Challenges include navigating potential market dynamics changes due to ACA subsidy adjustments, but Oscar Health is proactively addressing these concerns.

Oscar Health posts record revenue and profitability, eyes market expansion

Oscar Health delivered robust Q1 results, showcasing strong revenue growth, improved profitability, and strategic market expansion initiatives.
Despite facing challenges in achieving total company adjusted EBITDA profitability, the company's financial stability and growth prospects remain promising.
With a focus on operational efficiency and long-term strategic vision, Oscar Health is well-positioned to capitalize on market opportunities and drive sustained growth.

Oscar Health reports strong Q2 results, eyes growth through technology

Oscar Health's Q2 2024 earnings call showcased robust financial performance, driven by revenue growth and improved EBITDA. The company's membership expansion and strategic focus on technology-driven engagement are key strengths. Challenges include policy uncertainties and meeting raised guidance, while opportunities exist in market resonance and technological advancements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Harvard Business School classmates Josh Kushner, Mario Schlosser, and Kevin Nazemi decide to start a company to demystify health insurance.

Oscar, named after Kushner's great grandfather, raises $51.5 million through Series A, AA, and AAA funding from Gary Vaynerchuk, Dave Gilboa, Khosla Ventures, Lerer Ventures, General Catalyst Thrive Capital, Founders Fund, Kal Vepuri, BoxGroup and more, with a pre-money valuation of $70 million.

Series A4 funding drops a nice $30 million from investors into Oscar's wallet, bumping its valuation to $310 million.

Oscar secures $80 million in Series A5 funding, mostly from Formation 8. Pre-money valuation reaches $500 million.

Nearly 150,000 members call themselves Oscar-insured across four states alone (NY, NJ, CA, & TX).

Oscar's member services team sets up camp in Tempe, Ariz.

Mount Sinai Health System partners to open the Oscar Center, offering primary care, mental health, and wellness services to members—sort of like a fancy urgent care. 😎

Oscar offers coverage to New York small businesses for their employees. 

The Cleveland Clinic collab drops in the Midwest market to cover individuals across northeastern Ohio. 

Oscar expands to new regions, including Tennessee, Ohio, Texas, New Jersey, and California.

Hey, y’all: A partnership with Humana helps Oscar cover small businesses up to 50 employees in Nashville, Tenn.

Series G round nets Oscar $165 million in funding, zooming the estimated value to a whopping $3.2 billion.

Alphabet (parent company to Google) decides to invest, cutting Oscar a check for $375 million.

The "Cigna + Oscar" collab brings together Cigna's vast network to Oscar's member-focused experience for small businesses. 

Gary Vaynerchuk and Khosla Ventures go for round 2, but this time, a sweet $225 million with the help of Builders VC.

Tiger Global Management invests $140 million in Oscar, as the company's member count exceeds 400,000.

Oscar begins trading on the New York Stock Exchange under the ticker $OSCR.

Acacia Research

Inseego

Finding stocks with solid growth potential is essential to take advantage of new chances in today's volatile market. These three exceptional firms each provide solid arguments for considering them as potential stocks to buy to double your money.

3 Undiscovered Stocks Set to Double Your Money

Oscar Health reportedly aims to expand its presence in the employer market by providing more affordable health plans for small- and medium-sized businesses (SMBs). Using its position in the Affordable Care Act market, Oscar Health aims to compete with larger insurers and increase transparency on pharmacy benefits, CNBC reported Friday (June 7).

Oscar Health Aims to More Than Double Membership by 2027

Oscar Health CEO Mark Bertolini outlined the health insurers three-year plan to become a bigger player in the employer market ahead of the company's investor day. Bertolini says Oscar can leverage its position in the ACA market to compete with larger insurers to provide more affordable health plans for small- and mid-sized companies.

Oscar Health CEO Mark Bertolini is ready to take on the employer market

Oscar Health is doubling its “market footprint” over the next three years to grow its business selling individual health insurance known as Obamacare under the Affordable Care Act as well as a new form of coverage for workers and employers.

Oscar Health To Double Insurer's Market Reach

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Wall Street Bulls Look Optimistic About Oscar Health (OSCR): Should You Buy?

Atmos Energy

Strayer Education

Trip.com

Vital Farms, Inc.

The crux of safe investment lies in choosing a company that is not burdened with debt, as a debt-free stock is almost impossible to find. You may add VITL, TCOM, ATO, STRA & OSCR to your portfolio.

5 Low-Leverage Stocks to Buy as Inflation Data Meets Expectation

American Coastal Insurance Corp

Hamilton Insurance Group Ltd

American Coastal (ACIC), Hamilton Insurance (HG) and Oscar Health (OSCR) are three insurance stocks that you can look into as interest rates stay higher for longer.

3 Insurance Stocks to Buy as Interest Rates Remain High

Oscar Health (OSCR) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Oscar Health (OSCR) Is Attractively Priced Despite Fast-paced Momentum

Oscar Health (OSCR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Oscar Health, Inc. (OSCR) Hit a 52 Week High, Can the Run Continue?

Fast-paced Momentum Stock Oscar Health (OSCR) Is Still Trading at a Bargain

Oscar Health (NASDAQ: OSCR) stock price is firing on all cylinders this year. It has soared by 120%, making it one of the best performers in the Russell 2000 index.

Here's why Josh Kushner's Oscar Health (OSCR) stock is soaring

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, today announced that Chief Financial Officer, Scott Blackley, is scheduled to present and provide a business update at the BofA Securities 2024 Global Health Care Conference on Wednesday, May 15, 2024 at approximately 8:40 AM PT (11:40 AM ET) in Las Vegas, NV. All interested parties are invited to listen to a live webcast of the fireside chat by visiting www.ir.hioscar.

Oscar Health, Inc. Announces Participation in BofA Securities 2024 Global Health Care Conference

Insurance platform Oscar Health recorded its first-ever net profit amid record customer enrollment in Affordable Care Act plans. During an earnings call Tuesday (May 7), CEO Mark Bertolini said that total plan membership was up 42% during the quarter as “Obamacare” enrollment soared.

Oscar Health: Gig Workers Drive Record Jump in ‘Obamacare' Enrollment

Oscar Health, Inc. (NYSE:OSCR ) Q1 2024 Earnings Conference Call May 7, 2024 8:00 AM ET Company Participants Chris Potochar – Vice President-Treasury and Investor Relations Mark Bertolini – Chief Executive Officer Scott Blackley – Chief Financial Officer Conference Call Participants Stephen Baxter – Wells Fargo Adam Ron – Bank of America John Ransom – Raymond James Josh Raskin – Nephron Nathan Rich – Goldman Sachs Operator Good morning. My name is Ellie, and I will be your conference operator today.

Oscar Health, Inc. (OSCR) Q1 2024 Earnings Call Transcript

Oscar Health, Inc. (OSCR) came out with quarterly earnings of $0.62 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to loss of $0.18 per share a year ago.

Oscar Health, Inc. (OSCR) Surpasses Q1 Earnings and Revenue Estimates

Oscar Health reported its first-ever profitable quarter, easily beating views. Shares of the health insurer soared.

Oscar Health Soars As First-Ever Profit Crushes Views

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, today announced its financial results for the first quarter ended March 31, 2024. “Oscar reported strong first quarter results, showing year-over-year improvement across all core metrics and achieving positive net income,” said Mark Bertolini, CEO of Oscar Health. “Our performance lays a solid foundation for 2024, and gives us a clear line of sight into Total Company A.

Oscar Health Announces Results for First Quarter 2024

Ligand Pharmaceuticals

Penumbra

Several top-rated Zacks Medical sector stocks are standing out ahead of their quarterly reports on Tuesday, May 7.

Don't Overlook These Top Medical Stocks as Q1 Earnings Approach

Health care stock Oscar health is nearing a buy point after first quarter results. Oscar provides health insurance through the Affordable Care Marketplace.

Health Care Stock Gets A Big Lift From 'Obamacare' Growth Despite Continuing Losses

NEW YORK & BOSTON--(BUSINESS WIRE)-- #VC--Floating Point, an early stage venture capital firm investing in complex sectors, today announced the closing of its $70 million second fund. Floating Point looks deep in overlooked sectors to back expert founders building first of their kind companies. Their portfolio includes category-defining companies such as Altana, Commons Clinic, Sun Day, Floodbase, and Wheeler Bio. Floating Point now manages more than $150 million in assets on behalf of a wide range o.

Floating Point Closes Second Fund to Invest in Complex Sectors

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar” or the “Company”) (NYSE: OSCR), a leading healthcare technology company, will host its 2024 Investor Day on Friday, June 7, 2024 in New York City. Management will discuss the Company's corporate strategy, financial performance, and long-term financial targets. The event will begin at 9:00 AM ET. A live webcast to the presentation and the presentation materials will be available on Oscar's investor relations website (www.ir.hioscar.com). The.

Oscar Health, Inc. to Host 2024 Investor Day

NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, will release its first quarter 2024 financial results before the market opens on Tuesday, May 7, 2024. Management will review these results in a conference call beginning at 8:00 AM (ET). The call-in number and webcast link are as follows: Live Call: (888) 596-4244 Conference ID: 776-8132 Webcast Link The call will be archived and available on Oscar's investor relations website (www.ir.

Oscar Health, Inc. 2024 First Quarter Conference Call

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Oscar Health, Inc. (OSCR) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Why Fast-paced Mover Oscar Health, Inc. (OSCR) Is a Great Choice for Value Investors

Oscar Health, Inc. (OSCR) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

Despite Fast-paced Momentum, Oscar Health, Inc. (OSCR) Is Still a Bargain Stock

Oscar Health, Inc. (OSCR) Q4 2023 Earnings Call Transcript

News for Oscar Health Stock (OSCR)